~~<i id='5367817CFD'><strike id='5367817CFD'><tt id='5367817CFD'><pre id='5367817CFD'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

fashion

author：entertainment 2025-09-28 01:35:49 - browse：551

Aduhelm, a pioneering treatment for Alzheimer’s disease that collapsed under corporate mistakes and regulatory controversy, is now a cautionary tale in pharmaceutical history.

This week Biogen said it would no longer sell or study the medicine, which first won approval in 2021, ending an era for one of biotech’s storied companies and leaving the rest of the industry to piece together the lessons of a would-be blockbuster that never took off.

STAT reporters took a stab at the Aduhelm legacy — for biotech, Biogen, and Alzheimer’s research — on a recent episode of the Readout LOUD. Here’s an edited transcript of that conversation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Blinken talks high

Wikipedia

leisure time

focus

leisure time

Wikipedia

hotspot

CDCDirectorMandyCohenCliffOwen/APThenewdirectoroftheCentersforDiseaseControlandPrevention,MandyCohen

WSS

Biogen says it will cut costs by $700 million, slash 1,000 jobs

In the gardens at Boston Children's Hospital, families find sanctuary

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Superbugs, antibiotic resistance get scrutiny in congress

Inflation cooled significantly in June, bringing price hikes close to normal levels

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

focus

fashion

Wikipedia

BioMarin wins approval for gene therapy to treat hemophilia A

Watch the official trailer for 'Ahsoka' series

New air purifier tech could be key to improving indoor air quality

New Alzheimer's drugs heat up race for early detection blood tests

Tori Bowie and the unacceptable rates of Black maternal death

Device maker Teleflex to acquire urology company for $600M

23andMe had bad news about my health. I wish a person had delivered it

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Walensky prepares to leave CDC — and Congress — behind

Will the FTC rein in IQVIA's health data empire?

leisure time

Iran's president begins a rare visit to Africa 'to promote economic diplomacy'

Watch the official trailer for 'Ahsoka' series

CDC Director Mandy Cohen on transparency, trust, and health

New lawsuit accuses health insurer Cigna of denying claims in bulk

Grail's uphill battle for Medicare to cover its cancer screening test

What it's like to live with paralysis for one psychologist

focus

leisure time

Wikipedia

hotspot